EN
简体
繁体
EN
简体
繁体
About Us
Company Overview
Milestones
Our Team
Investors
Partnership & Recognition
Contact Us
CANbridge in Rare Disease Community
Pipeline & Products
Pipeline
Rare Oncology
Rare Diseases
Gene Therapy
Other Onc.
Approved Products
Hunterase®
Nerlynx®
Caphosol®
Investors
Information Disclosure
Listing Documents
Financial Reports
Announcements & Circulars
Corporate Governance
Stock Information
Presentations & Webcasts
Analyst Coverage
Financial Calendar
Email Alert and IR Contact
Media & News
Media Reports
Press Release
Corporate Culture & Career
Corporate Culture
Open Positions
Webcasts
2022 Annual Results Webcast
Mar 31, 2023
2022 Interm Results Webcast
Aug 25, 2022
Jefferies Healthcare Conference
June 8-10, 2022
Presentations
2022 Annual Result Presentation
Mar 31, 2023
Corporate Presentations
Nov 2022
2022 Interim Result Presentation
Aug 25, 2022
2021 Annual Result Presentation
Mar 23, 2022
